Investing.com -- Aytu BioPharma (NASDAQ:AYTU) stock gained 2.6% on Monday after the company announced the commercial availability of its newly approved depression treatment EXXUA in the United States.

Moment of Clarity has published a new educational article titled “Spravato for Bipolar Depression Treatment“, providing an in-depth exploration of how esketamine therapy is being used to manage ...

I was enjoying the broadcast of the Padres game when a depressing commercial appeared about an anti-depression medication. What made it so gloomy was the long list they itemized referencing the side ...

Credit: Getty Images Our helpful fact sheet informs patients about the risks, benefits, and considerations associated with postpartum depression medication. Our easy-to-read fact sheets provide ...

I was in my second year of medical school when Solomon Snyder, a professor of neuroscience at Johns Hopkins Medical School, presented to our class his revolutionary work in brain chemistry and ...

August 30 marks National Grief Awareness Day, a significant observance that highlights the often-overlooked emotional impact of loss and emphasizes the importance of supporting people through the ...